[Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken)].
In a group of 40 patients with acute myocardial infarction and ectopic ventricular or atrial beats or tachycardia, the effect of Visken has been tested by means of 3 i.v. injections of 0.4 mg each at intervals of 15 min. The results showed that Visken has a good effect on these rhythm disturbances and can be administered without danger, provided due regard is had to the contraindications. Beta-blockade is especially indicated when the sinus rate is raised and the conventional antiarrhythmic drugs have proved ineffective.
D001794:Blood Pressure; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002496:Central Venous Pressure; D006339:Heart Rate; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000150:complications; D010869:Pindolol / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D010869:Pindolol
Behandlung von Rhythmusstörungen nach akutem Herzinfarkt mit einem beta-Rezeptoren-Blocker (Visken)